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Abstract
! Bacteriophage transduction events play a contributive role in bacterial gene 
diffusion in ecosystems comprised of natural microbial populations.  The rate at which 
these phage-mediated genetic transfers occur in wastewater ecosystems is not well 
understood.  This work describes the effectiveness of a genetically engineered 
biotinylated bacteriophage T4 system as a tool for examining transduction event rates 
and compositions in environments that pose increased risk of antibiotic resistance 
proliferation.
! Antibiotic use has steadily increased over the past century, giving rise to 
antibiotic resistance in microorganisms.  Agricultural, medical, and industrial use of 
antibiotics produces waste teeming with residual antibiotic compounds that are collected 
to form novel microbial ecosystems.  These wastewater microbial communities include, 
among others, bacteria and their viral parasites, bacteriophage.  Bacteriophage can 
transfer genetic material between bacterial hosts through a phenomenon known as 
transduction, thus creating circumstances that can contribute to the spread of antibiotic 
resistance genes.  Wastewater ecosystems that contain vestigial antibiotic compounds 
may produce selective breeding grounds for the development of antibiotic resistant 
microorganisms.  This study aimed to elucidate the role of bacteriophage in the spread 
of antibiotic resistant genes under these environmental conditions using a novel biotin-
based tagging and recovery system.  This system analyzed the unbiased tagging of 
bacteriophage particles, infection of host bacteria, and the recovery of biotinylated 
phage progeny as means to investigate phage-mediated transduction rates.  
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! A recombinant bacteriophage T4 with biotin carboxylase carrier protein (BCCP) 
fused to the small outer capsid (SOC) acted as the tagged bacteriophage in this work.  
Numerous techniques for phage propagation and purification were optimized for this 
application, indicating important information about the feasibility of using this engineered 
bacteriophage in a natural ecosystem.  The genetic instability and susceptibility to 
selective pressures of the biotinylated bacteriophage, even under optimally controlled 
conditions, resulted in the deactivation of the phage"s biotinylation capabilities.  The 
results of this examination indicate the impracticality of using this genetic-based 
biotinylation approach as a method for measuring transduction events rates in natural 
ecosystems.
iii
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Introduction
!
! The most abundant biological entity on earth is the bacteriophage, with global 
numbers estimated to be in excess of 1031 (Furhman, 1999).  The highly efficient 
adaptive gene transfer mechanisms employed by bacteriophage exude tremendous 
influence on microbial ecosystems.  Bacterial diversity and population dynamics are 
linked to bacteriophage effects on a genetic level.  Phage mediated gene transfer, or 
transduction events, in marine microbial systems have been shown to occur at a rate of 
2 x 1016 events per second (Canchaya, 2003) and among a wide range of bacterial 
species in freshwater ecosystems (Kenzaka, 2010).  Transduction events have been 
studied in soil (Zeph, 1988), freshwater (Morrison, 1978; Saye, 1987), and marine 
environments(Jiang, 1998), but the mixture of medical, agricultural, and industrial waste 
in wastewater treatment facilities is of particular concern with regard to human health.  
Environments consisting of wastewater and activated sludge contain vast stores of 
bacteriophage diversity (Ewert, 1980; Hantula, 1991; Muniesa, 1998).  Bacteriophage 
populations actively replicate in these wastewater environments (Khan, 2002) and have 
been shown to infect hosts across strains, species, and genera (Beumer, 2005; Khan, 
2002).  Although it has been shown that bacteriophage play a role in the spread of 
genes that are potentially harmful to humans (Muniesa, 1998; Muniesa, 2004), accurate 
transduction rates have yet to be determined outside optimized bench scale 
experiments (Withey, 2005).  
! The relatively recent increase in phage-based biotechnological applications 
include bacteriophage therapy for antibiotic-resistant microbial pathogens (Payne, 2000; 
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Bull, 2002; Matsuzaki, 2005), bacteriophage regulation of wastewater bulking and 
foaming (Thomas, 2002; Withey, 2005), phage-based biosensors for food and water 
quality control (Petty, 2007), and phage applications for controlling bacterial 
contaminants (Clark, 2006).  With the expansion of bacteriophage use, environmental 
discharges are bound to increase.  Therefore, identifying and characterizing 
bacteriophage transduction events in wastewater ecosystems plays a critical role in 
understanding risks associated with the phage-mediated spread of detrimental human 
health-associated genes in the environment.
! The overall goal of this research is to expand upon established knowledge 
pertaining to the characteristics, rates, and methods of genetic exchange among 
genetically engineered microorganisms.  A specific objective of this work is to analyze 
and confirm that a genetically engineered bacteriophage T4 was labeled with a biotin-
binding gene, biotin carboxylase carrier protein (BCCP), allowing for isolation of the 
tagged phage post-infection and subsequent analysis of the accumulated genomic 
permutations.  The aforementioned labeling technique allows for an unbiased approach 
to identification and isolation of intended phage progeny after a natural infection process 
followed by bacterial host lysis in a natural ecosystem.  This approach technically 
addresses the proposed hypothesis that genetically engineered bacteriophage can 
serve as unbiased, indicative vectors of transduction events in an ecosystem.  The 
other expansive hypothesis that is addressed by this work is that bacteriophage have a 
greater propensity for broad host ranges than is customarily thought, thereby making 
their role in cross-species dissemination of genetic elements more consequential.  This 
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work is an analysis of experimental designs utilizing a biotinylated bacteriophage T4 as 
an indicator of host range limitations, a gene transfer agent, and the field application of 
a genetically modified organism in a wastewater environment.
Background
!
! The established description of the lytic bacteriophage T4 infection cycle includes 
the phage attachment to specific receptor sites on the host cell"s surface.  Numerous 
molecules can act as phage receptor sites and proteins that are exploited by phage 
generally serve important roles for the effective functioning of the bacterial cell.  After 
phage adsorption to the host cell, the phage injects its DNA through the bacterial cell 
wall.  This process requires energy and initiates conformational changes in the phage 
structure.  These structural changes result in the contraction of the phage tail sheath, 
thereby forcing the hollow tail into the host cell.  Small fibers located on the end of T4 
phage tails serve as anchors for the baseplate attachment to the cell surface receptors.  
As the phage capsid is drawn to the cell surface, the baseplate transforms from a 
hexagonal shape into a star shape, tail diameter increases as it is shortened, and an 
internal pin-like apparatus contacts the outer membrane of the host cell.  It is during this 
time that the viral genetic material is injected into the host cell through the tail.  This 
injection process is powered by a proton motor force, compliments of the bacterial cell.  
After the phage DNA is injected into the host cell, early viral genes responsible for 
phage genome replication and modification of host cell machinery for maximum phage 
reproduction are expressed.  Bacteriophage T4 synthesizes concatemers, or long 
continuous chains of genomic DNA, which are later enzymatically cut to produce 
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discrete phage genomes.  Later phage genes that are expressed produce protein 
subunits for capsid construction.  Progeny phage capsids are packed with phage 
genomes and enzymes are produced to lyse the host cell.  These lysis-inducing 
enzymes include holin, which disrupts the cell"s cytoplasmic membrane, and lysozyme, 
which degrades peptidoglycan in the cell wall.  This disruption of the cell wall and 
membrane causes the host cell to burst, allowing for the release of the progeny 
bacteriophage (Abedon, 2005).  
! Transduction events contributing to lateral gene transfer in microbial 
environments were considered negligible until the ubiquity of viruses in nature was 
better understood.  Bacteriophage mediated transduction is now thought to play a 
significant role in microbial evolution (Winebauer, 2004).  During the infection cycle, the 
packaging of foreign DNA into replicating phage capsids follows two trends:  specialized 
and generalized.  During specialized transduction, distinct portions of the host genome 
are incorporated into the phage capsid, thereby becoming part of the progeny phage 
genome.  By contrast, generalized transduction consists of the replicating phage taking 
up any DNA fragments residing in the microenvironment of a host bacterial cell.  A 
bacteriophage that has the ability to undergo generalized transduction can incorporate a 
host genome in its entirety, limited only by the holding capacity of its capsid.  This can 
occur in theory, however, it is more likely that small, random fragments will be mixed 
with the replicating phage genome due to the phage capsid holding capacity typically 
being several orders of magnitude smaller than the host genome.  Once these abundant 
segments of DNA are packaged into the capsids of phage progeny, they can be 
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delivered to other bacterial hosts, allowing for this foreign DNA to be incorporated into 
the bacterial host genome.  DNA fragments that are taken up by transducing 
bacteriophage can include exotoxin genes (Casas, 2006), genetic mobile elements 
(Breitbart, 2003), and antibiotic resistance genes (Muniesa, 2004).  Bacterial genome 
analyses have shown that up to 20% of bacterial genomes are made up of these phage 
related genetic elements (Casjens, 2003).  Specifically, it has been found that 15% of 
the E. coli genome consists of genes that have been acquired through horizontal gene 
transfer (Lawrence, 1998).
! The constant interactions between bacteria and phage produces vast opportunity 
for repeated transfer of genetic material not only between hosts, but between phage 
populations.  A conceptual paradigm lies in the T-even bacteriophage with regard to 
horizontal gene transfer mechanisms.  These phage have been shown to share a core 
genome that constitutes approximately 12-15% of their coding potential and some of the 
genes that make up this genome have spread to the genomes of a diversity of bacterial 
genera (Petrov, 2010).  Several distinct transduction-related processes that are utilized 
by T-even bacteriophage include evidence for highly variable DNA modification systems 
that can produce homologous recombination events with co-infecting phage within the 
host (Mosig, 2006).  The genome of bacteriophage T4 shows evidence of a particularly 
active enzyme system for homologous recombination that has evolved to mediate non-
homologous exchanges between slightly similar or disparate genetic sequences in all 
DNA-based biological systems (Petrov, 2010).  These exchanges can occur as genetic 
replacements resulting from traditional reciprocal exchanges with foreign genetic 
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entities, or as genetic additions produced from the initiation of DNA replication through 
the invasion of intracellular phage DNA pools by free 3" ends of foreign DNA (Mosig, 
2006).  Intron and intronless homing endonucleases are coded and deployed by T-even 
bacteriophage, both of which utilize homologous recombination between phages co-
infecting a bacterial host to transfer of genetic information from the endonuclease-
encoding genome to a endonuclease-free recipient (Edgell, 2010; Belfort, 2009; Belle, 
2004; Liu, 2003).  These homing endonucleases can contribute to lateral gene transfer 
by mobilizing introns, flanking DNA sequences, and distant genes or gene clusters in 
phage.  Additionally, the head size plasticity of phage T4 plays a critical role in the ability  
to take up extra, foreign DNA during infection (Mosig, 2006).  The T4 DNA packaging 
system can encase approximately 170 kb of foreign DNA into a capsid with no 
difference in packaging efficiency between mature phage DNA and extraneous genetic 
material (Rao, 2008).  All of the aforementioned bacteriophage life cycle characteristics 
suggest that an exuberant level of genetic exchange has occurred in the past and 
continues to transpire not only among phage populations, but between the bacterial 
hosts that drive viral propagation.  
! Previous evaluations of gene transfer risks associated with bacteriophage have 
produced the scientific zeitgeist that acknowledged transduction as a mediator of 
genetic transfer, but narrow host ranges of phage generally limited the phenomenon to 
a small fraction of bacterial hosts with which the phage can infect and exchange genes.  
Evolutionary theory, and ever increasing experimental evidence, suggests that phage 
are not restricted to a single host species and many phage display broad host ranges.  
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A sewage phage, SN-T, has been shown to infect six genera of bacteria (Jensen, 1998). 
Phage isolates from activated sludge showed that 15 of 17 had broad host ranges and 
12 could infect across bacterial genera (Thomas, 2002).  Another study showed that 
phage derived from activated sludge could infect both Gram positive and Gram negative 
bacterial species (Khan, 2002).  Broad host range bacteriophage were thought to be 
misrepresented by enrichment and isolation practices that selected for narrow host 
range phage.  These biased, conventional techniques consist of plating phage lysate on 
varying lab grown bacterial hosts and noting plaque formation, thereby indicating a 
limited representation of phage host ranges.  This approach grossly underestimates the 
number of bacterial hosts that the phage may interact with in an uncontrolled 
environment, giving a very restricted representation of phage host ranges.  The 
technical limitations of phage host range analyses are compounded by phages" abilities 
to modify their ability to recognize and attach to potential host cells in a rigorously 
dynamic bacterial environment (Wilkinson, 2001).  A fundamental application of 
evolutionary theory provides logic to the concept of higher frequency broad host ranges 
in bacteriophage:  species in a diverse microbial community occur at dynamically low 
abundance in relation to environmental challenges, thereby making it selectively 
advantageous for phage plasticity to allow for infection and propagation in a myriad of 
genetically divergent hosts.  This scenario would increase the prospect of phage 
mediated gene transfer due to a wide range of hosts with which to interact.
! An increased interest in bacteriophage exploitation for biotechnological and 
economic purposes has been steadily increasing, thereby intensifying the potential for 
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gene transfer in the environment (Petty, 2006).  The increase in antibiotic resistant 
bacterial strains has produced various bacteriophage applications in hopes of alleviating 
the problem.  Bacteriophage applications to hospital surfaces and objects has been 
shown to decrease the transmission of E. coli infections in children and adults 
(Drozdova, 1998), burn wounds have been treated with bacteriophage cocktails to 
prevent Pseudomonas aeruginosa and Staphylococcus aureus infections (Merabishvili, 
2009), and a whole host of other medical-based applications have been described with 
increasing occurrence (Marks, 2000; Chanishvilli, 2001; Skurnik, 2006).  Veterinarian 
uses of bacteriophage include spraying aqueous bacteriophage solution on litter in calf 
pens to prevent E. coli infections in calves (Smith, 1987), sewage-derived phage 
cocktails applied to pig skin reduced Salmonella Typhimurium infections (Hooton, 2011), 
in vivo treatment of chickens to prevent Salmonella (Dahiya, 2006) and Clostridium 
perfringens (Toro, 2005) colonization, Staphylococcus aureus mastitis in lactating dairy 
cattle (Gill, 2006), and control of Aeromonas salmonicida infections in brook trout 
(Imbeault, 2006).  As anti-infective agents, phage have been approved by the FDA for 
use as a spray to control Listeria monocytogenes on consumer deli meat products as 
well as various methods to control pathogens on fruits, vegetables, and dairy products 
(Hudson, 2005).  In addition to the bio-control uses for phage, phage-based biosensors 
have been developed to detect food borne pathogens (Petty, 2006) and phage-based 
techniques for treating wastewater bulking and foaming have been deployed (Withey, 
2005).  This widespread use and exploration of phage utility is resulting in an increased 
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release of phage into the environment, particularly in wastewater ecosystems, where a 
better understanding of phage-mediated gene transfer must be achieved.    
! An approach to measure risk associated with the increase in phage released into 
the environment and how they interact within natural ecosystems relies on biomolecule 
tagging and immobilization.  Passive adsorption is one of the most straightforward 
methods for attaching biomolecules to hydrophobic polymeric particles.  Biomolecules 
are commonly immobilized through passive adsorption onto polystyrene tubes and other 
surfaces with adequate surface modifications.  This passive approach is beneficial in 
many applications of immobilizing biomolecules because it requires little additional 
treatment of the target molecules and substrate.  The passive nature of this approach 
depends on the formation of numerous weak bonds between targets, which can cause 
the immobilized molecule"s functional configuration to be altered (Wilson, 2001).  
Biotinylation alleviates this problem by creating a limited number of tighter bonds 
between the target molecule and the substrate (Hoogenboom, 1998).  Biotin, a vitamin 
and coenzyme vital to fatty acid synthesis and gluconeogenesis, can be covalently 
linked to DNA or proteins in a phenomenon known as biotinylation.  When biotin is 
bound to a protein, it can be immobilized on avidin-coated surfaces.  This technique has 
been used extensively in a variety of ligand-binding studies (Bayer, 1976; Heitzman, 
1974) and avidin is routinely replaced with streptavidin, which has a higher conjugate 
binding affinity.  The biotin-streptavidin bond is one of the strongest non-covalent 
interactions found in nature, with a dissociation constant of approximately 10-14 mol/L 
(Green, 1975).  Numerous techniques utilize this strong interaction, which can allow for 
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the sensitive detection of biotinylated molecules.  Biotinylation is usually achieved by 
modifying protein amino groups with biotin-N-hydroxysuccinimide or other acylating 
agents.  This chemical approach to biotinylation has been applied to phage capsid 
proteins and coupled with streptavidin-coated bead interactions, it has been shown to 
increase capturing efficiency over previously described systems (Bennett, 1997).  
! The only biotinylated protein produced by E. coli is the biotin carboxyl carrier 
protein (BCCP), which is a 22-32 kDa subunit of acetyl-CoA-carboxylase (Fall, 1979).  
E. coli holoenzyme synthetase uses ATP to link biotin to the amino group of #-lysine 122 
in BCCP.  Several studies have reported biotinylation of fusion proteins in vivo which 
consisted of constructing biotin acceptor domains similar to BCCP-like acceptor proteins 
that could be fused to genes for heterogenous proteins (Cronan, 1990; Tatsumi, 1996; 
Li, 1992; Choi-Rhee, 2003; Yamano, 1992).  Additionally, phage T7 has been 
successfully engineered to display biotinylation peptides on its capsid surface and 
subsequent in vivo host E. coli biotinylation of the peptides by biotin-ligase protein, BirA 
(Edgar, 2006).  Streptavidin-coated quantum dots were used to detect, concentrate, and 
quantify the biotinylated progeny phage after host cell lysis, thereby indicating host E. 
coli infection events.  
! The work described herein utilized this biotinylating characteristic of E. coli and a 
BCCP fusion with the small outer capsid (SOC) protein of bacteriophage T4 to allow for 
the retrieval and enumeration of progeny phage after host cell infection in a wastewater 
ecosystem. The binding site on the SOC protein was not near the N- or C-termini, 
thereby minimizing the possibility of interrupting the interaction between SOC and the 
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phage capsid.  Additionally, it has been observed that SOC is nonessential for 
bacteriophage viability, but confers additional stability to the phage capsid structure 
against osmotic shock, pH fluctuations, and temperature denaturation, thereby making 
SOC a useful target for potentially benign protein fusions (Comeau, 2008).  This 
recombinant phage has been effectively immobilized onto streptavidin-modified 
surfaces without observable affects on phage infection efficiency (Tolba, 2009).  This 
technology could allow for the unbiased isolation of tagged phage particles and the 
quantitative characterization of transduction events through phage genomic analysis 
targeting host-derived 16S rRNA gene sequences and bacterial antibiotic resistance 
genes.  The isolation techniques utilized in this effort will allow for specific labeling of 
phage after host infection and swift retrieval from an environmental solution, relying 
heavily on the strong non-covalent binding interactions of biotin and streptavidin 
(Figure 1).
Phage Capsid Protein
(SOC)
Biotin Carrier Protein
(BCCP)
Biotin
Streptavidin 
(beads)
Figure 1.  Overview of bacteriophage biotinylation and retrieval system.
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Materials and Methods
Genetic Construction of E. coli K12-12017 host
! The host E. coli K12 (strain 12017) was grown in $ salt Luria Burtani broth (Table 
9) overnight in 100mL of culture medium at 37%, shaking at 200 rpm.  All following 
bacterial and phage incubations at 37% were incubated with shaking at 200 rpm, 
unless noted otherwise.  After incubation, 30µl of culture were transferred into 1.4mL of 
fresh $ salt Luria Burtani broth in 1.5mL microcentrifuge tubes and incubated at 37% 
for three hours.  After incubation, the tubes were transferred to ice and subsequently 
centrifuged for 30 seconds at 9,000 x g at 2%.  The supernatant was removed from the 
tubes and the pelleted cells were resuspended in 1mL of sterile, deionized H2O.  The 
resuspended cells were centrifuged at 9,000 x g at 2% and the supernatant was 
removed.  The remaining pelleted cells were resuspended in 30µl deionized H2O.  After 
resuspension, 1µl of pGlowBS2STOP (Figure 2) plasmid DNA at a concentration of 
600ng/µl was added to the cell mixture and transferred to an electroporation cuvette that 
was cooled on ice.  The electroporation device (Biorad, Hercules, CA) was set to the 
following settings:  T=2.5kV, C=50µF, R=125 ohms, S=2.45kV.  The field strength was 
calibrated to produce 12.25 kV/cm with a pulse length of 5-6 milliseconds.  After 
electroporation, the mixture was immediately resuspended in 1mL of super optimal 
broth with catabolite repression (Table 9) and transferred to a sterile microcentrifuge 
tube.  The culture was incubated at 37% for 70 minutes.  After incubation, 100µl of cell 
solution were spread on LBamp plates laced with 100mg/mL of ampicillin to act as a 
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selecting agent.  The plates were incubated at 37% overnight and observed for 
successful transformation colony growth.
! For purification of the pGLOWBS2STOP plasmid that contained the marker 
genes used in this study, a Wizard+ Miniprep kit (Promega, Madison, WI) was used 
according to manufacturer protocol.  The purified plasmid DNA was subjected to PCR 
and gel electrophoresis to validate primer functionality and gene presence.  Primers 
were designed to amplify fragments of marker genes found on the plasmid, thereby 
indicating the possible presence of the entire gene of interest.  Three marker genes on 
the pGlow plasmid were established as being:  the ampicillin resistance gene, ampR, 
the evoGlow Pp1 gene, pGlow, and the fluorescent marker gene, gfp, all of which were 
derived from the pGlow-Bs2-stop plasmid (Evocatal, Düsseldorf, Germany).  The ampR 
and evoGlow Pp1 genes required a 56% annealing temperature, while the gfp gene 
primer set required a 62% annealing temperature in the thermocycler programming 
(Table 3).  Each PCR was performed using PuRe Taq Ready-To-Go™ PCR Beads (GE 
Healthcare, Little Chalfont, UK), and primer sets were designed using primer3 software 
(MIT, Cambridge, MA) and commercially obtained from Operon.  All PCR primers were 
diluted to 100µM initially, and working stocks were further diluted to 5µM for PCR 
applications.  Each PCR reaction contained 1µl of each primer at 5µM concentrations, 
300ng of template DNA, and sterile deionized H2O to a total volume of 50µl per 
reaction.  Wide-Range DNA ladder (Takara Bio, Otsu, Japan) was used as a DNA 
molecular size marker in gel electrophoresis.  An Owl Easy Cast gel electrophoresis 
system (Thermo Scientific, Waltham, MA) was used for casting and running 1% agarose 
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gels with PCR products.  Tris-borate-EDTA buffer was used for agarose gel preparation 
and also electrophoresis.  Ethidium Bromide was mixed with molten agarose by adding 
4µl of EtBr (Fisher Scientific, Hampton, NH) for each 100 ml volume of agarose gel.  
The gels were run at 60V for approximately 45 minutes at room temperature and 
visualized in an UV photodocumentation device.  All subsequent gel electrophoreses 
utilized these parameters.
Table 1.  Biological entities utilized in this study.
Bacterial Host Escherichia coli (strain 12017)
Marker Plasmid pGlowBS2Stop
Bacteriophage BCCP-fused T4
Table 2.  Primers used for determining plasmid fidelity.
Primer Sequence
AmpR FW TTGCCGGGAAGCTAGAGTAA
AmpR RV AAGCCATACCAAACGACGACGAG
pGlow FW TGGAAGATAACCCGATCGTC
pGlow RV GATCGATGTTCAGTTCGTTCCA
gfp FW ACGCGTATGGCGTCGTTCCAGTCGTT
gfp RV AGATCTGCAGTCACTCGAGCAGCT
14
Table 3.  Polymerase chain reaction thermocycler protocol.  AmpR and pGlow 
primer sets required 56! annealing, and gfp primers required 62! annealing.
Activity Temperature Time
Denaturation (long) 95% 5 minutes
Denaturation (short) 95% 30 seconds (repeated 39X)
Annealing 56% or 62% 30 seconds (repeated 39X)
Extension (short) 72% 1 minute (repeated 39X)
Extension (long) 72% 10 minutes
Figure 2.  Map of pGlow-Bs2 plasmid used for marker genes in genetic analysis.
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Genetic Characterization of Biotinylated Bacteriophage T4
! The biotinylated bacteriophage T4 was developed by Mona Tolba at the 
University of Guelph.  The phage had been developed to use a biotin-binding peptide as 
an affinity tag that was displayed on the phage head as fusions with the Small Outer 
Capsid (SOC) protein.  The gene for the capsid-fused peptide was the biotin carboxyl 
carrier protein (BCCP), from acetyl-CoAcarboxylase of E. coli.  In addition to BCCP, the 
T4e lysozyme gene was also used as a marker gene to aid in qualitative and 
quantitative standards.  Polyethylene glycol 8000 (Fisher Scientific, Hampton, NH) and 
sodium chloride (Fisher Scientific, Hampton, NH) were used for the two-phase 
precipitation of bacteriophage T4.  The host E. coli K12 was grown in 100mL of LB 
medium at 37% overnight.  After incubation, cultures were centrifuged at 5800rpm for 
10 minutes at room temperature and the supernatants discarded.  The pellets were 
resuspended in 3mL of SM buffer and phage particles were added to a multiplicity of 
infection of 0.5.  The infected cultures were incubated for 20 minutes at 37% with 
intermittent swirling.  The cultures were then added to 500mL of 37% prewarmed LB 
medium, incubated at 37% and observed for visible lysis during an 8-12 hour period.  
After visible lysis, 10mL of chloroform (Fisher Scientific, Hampton, NH) were added to 
the cultures and incubated for 10 minutes at 37%.  The lysed cultures were then cooled 
to room temperature and transferred to a sterile 1000mL separation funnel.  At room 
temperature, 32.5g of PEG8000, 1g Dextran Sulfate, and 8.75g of NaCl were added to 
500mL of culture, mixed with gentle swirling and stored at 4% overnight.  The liquid 
supernatant mixture were then transferred to sterile polypropylene bottles and stored on 
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ice for 1 hour.  After cold incubation, the precipitated bacteriophage particles were 
centrifuged at 8300rpm for 10 minutes at 4%.  The supernatants were discarded and 
the bottles were allowed to stand inverted at a titled position for 5 minutes.  The 
remaining pellets were rinsed and resuspended with 8mL SM buffer for each 500mL 
bottle and the bottles were placed on their sides for 1 hour at room temperature to allow 
for pellet saturation.  An equal volume (8mL) of chloroform was added to the bottles to 
extract the cellular debris and PEG from the suspension.  The mixture was vortexed for 
30 seconds and centrifuged at 3000g for 15 minutes at 4%, and the aqueous phase 
was recovered.  
! Phage plaque titer plates were made using LB agar as the base medium and LB 
1% agarose as the top medium.  Host E. coli K12 was grown at 37% overnight, and 
200µl were transferred to a sterile 15 ml polypropylene tube.  The overlay medium, LB 
1% agarose was melted and cooled to 42% to prevent heat shock effects on the 
bacterial cells.  Once cooled, 4 ml of the top agarose was added to the 15 ml 
polypropylene tubes containing the host E. coli K12 and gently mixed.  The mixture was 
poured onto 37% warmed LB agar plate and allowed to solidify at room temperature.  
After solidifying, serial dilutions of the phage precipitate were pipetted onto the top layer 
containing the host E. coli K12 in LB agarose.  The plates were incubated for 12 hours 
at 37% in the dark.  Bacteriophage enumeration occurred after the incubation period to 
determine viral concentration in the solution.  This plaque assay was repeated after the 
following CsCl ultracentrifugation procedure to determine phage concentration and 
particle loss.
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Table 4.  Cesium chloride density gradient concentration calculations and 
associated refractive indexes.
Density " (g/ml) CsCl (g) Salt Magnesium 
Buffer (ml)
Refractive Index #
1.45 60 85 1.3768
1.50 67 82 1.3815
1.70 95 75 1.3990
!
! For density gradient ultracentrifugation, three CsCl gradients were prepared 
(Table 4). For each ml of bacteriophage suspension, 0.5 g of CsCl (Fisher Scientific, 
Hampton, NH) was added and mixed until all of the CsCl was dissolved.  The CsCl 
gradients were added to an Ultra-clear ultracentrifuge tube (Beckman Coulter, 
Pasadena, CA), 7.6 ml of each CsCl concentration was added in the order of 1.70& at 
the bottom, 1.50& in the middle, and 1.45& on the top.  Additionally, 13 ml of 
bacteriophage solution was added to the top of the CsCl gradient layers.  Each gradient 
zone was marked on the tube with a permanent marker to indicate the layers.  The 
suspension was centrifuged at 87,000g (22,000 rpm Beckman SW28 rotor) for 2 hours 
at 4%.  After ultracentrifugation, a sterile syringe was used to puncture the side of the 
tube in the density above the 1.5 g/ml CsCl region where the bacteriophage particles 
formed a band.  The contents were transferred to a sterile ultracentrifuge tube, filled 
with 1.50 g/ml CsCl, and sealed.  The solution was centrifuged at 150,000g (41,000 
Beckman Ti50 rotor) for 24 hours at 4%.  The band of bacteriophage particles was 
collected as previously described and stored at 4%.
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! For bacteriophage genomic DNA extraction, the volume of the band containing 
purified bacteriophage particles was measured and 0.1 volume of 2M Tris-Cl, pH 8.5 
and 0.2M EDTA (Fisher Scientific, Hampton, NH) were added and inverted to mix.  After 
thorough mixing, 1 volume formamide (Fisher Scientific, Hampton, NH) was added, 
gently vortexed to mix, and left to stand at room temperature for 30 minutes.  
Subsequent addition of 2 volumes, each equal to the original bacteriophage band 
volume, of 100% ethanol was mixed into solution and centrifuged for 2 minutes at 
10,000g for 2 minutes at room temperature.  The supernatant was discarded and the 
remaining pellet was rinsed with 70% ethanol.  All droplets of residual ethanol were 
removed with a pipette and the moist, genomic DNA-containing pellet was resuspended 
in TE buffer.
! PCR primer sets were designed using primer3 software (MIT, Cambridge, MA) 
for the BCCP and T4e genes (Table 5).  The target amplicon size for BCCP was 146 bp 
and the T4e amplicon was 139 bp.  The PCR protocol followed the same general 
program as described in Table 3, with the exception of the annealing temperature being 
set to 58% for both BCCP and T4e primer sets.  PCR reactions tubes, gel 
electrophoresis, staining, and visualization followed the same parameters previously 
described.
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Table 5.  PCR primer names and sequences for BCCP and T4e gene amplification.
Name Sequence
BioFW CAAGTTTCCCTGTGATGCAAC
BioRV GGGTGCGGTAGAAAGTACCA
T4eFW TTTGCGCGATTAGGTGTTTG
T4eRV GTTCGTCGCTGTGCATTGAT
! After PCR verification of BCCP and T4e presence in the bacteriophage genomic 
DNA, a TOPO-TA cloning kit (Invitrogen, Carlsbad, CA) was used to clone the gene 
fragments using pcr4 cloning vector and TOP10 E. coli cells.  Cloning was followed by 
Wizard+ SV miniprep (Promega, Madison, WI) application to purify the plasmid DNA for 
further PCR verification.  Plasmid DNA was then used as the template for PCR 
amplification of the BCCP and T4e genes.  All PCR parameters were identical to those 
previously described.
Multiplicity of Infection Optimization
! Necessity dictated that the host E. coli K12 growth characteristics be determined 
to allow for effective bacteriophage infection and propagation.  The mercurial 
relationship between bacteriophages and their hosts can result in highly variable 
infection rates, which can directly affect the optimal multiplicity of infection necessary for 
bacteriophage propagation.  To standardize and streamline the process, optical density 
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measurements (600 nm) were taken at specific time intervals of bacterial growth and 
subsequently compared to cfu/ml dilutions on growth medium.  
! Three cultures containing Luria Burtani broth supplemented with 100 mg/ml 
ampicillin were inoculated with E. coli K12 pGlowBS2Stop from single colonies on 
LBamp100 agar plates and incubated overnight at 37%.  The cultures' OD600 were 
measured after overnight incubation and 1 ml of overnight culture was transferred to 
100 ml of pre-warmed to 37% LBamp100 broth.  The initial OD600 was measured 
immediately after the transfer and the cultures were incubated at 37%.  The optical 
density of the cultures were measured every hour and returned to incubation between 
measurements.  In addition to optical density measurements, an additional 1 ml of 
culture was removed at each time point and serially diluted in LBamp100 broth for spread 
plating on LBamp100 agar plates.  The viable cell count plates were incubated at 37% 
over night in the dark and quantified the next day.  The viable cell counts were matched 
with the optical density measurement time points for an observable correlation and the 
bacterial growth phases were mapped according to time and growth conditions using 
Prism 4 statistical software (GraphPad Software Inc, La Jolla, CA).
! The optimal multiplicity of infection value was determined by adding a known 
quantity of infectious viral particles to a known quantity of viable bacterial cells during a 
specific growth phase in batch culture.  This was achieved by growing E. coli K12 host 
overnight at 37% and transferring 1 ml to 200 ml of fresh LB broth.  The culture"s O.D.
600 was measured until the density reached approximately 0.4 and bacteriophage T4 at 
a M.O.I. of 0.5 (one viral particle per two bacterial cells in solution) was added to the 
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culture.  The concentration of the bacteriophage sample added to bacterial culture was 
quantified through plaque assay enumeration.  After the transfer and bacteriophage 
inoculation, the culture was incubated at 37% and optical density at 600 nm was 
monitored during the post-inoculation period and the presence of visible cellular debris 
accumulation was observed.  The lysed culture was treated with the addition of 2 ml of 
chloroform and centrifuged at 10,000g for 5 minutes at room temperature and the 
supernatant was transferred to a sterile polypropylene tube.  The solution was filtered 
through a 0.45 µm membrane filter, serially diluted with SM buffer, plated onto top-
agarose containing host E. coli K12 host and incubated at 37% overnight in the dark.  
The top agar plates were examined to determine bacteriophage titers of the infected 
culture.
Bacteriophage Purification and Concentration
! The previously described method of isopycnic CsCl gradient ultracentrifugation 
for purifying and concentrating bacteriophage samples was found to be inadequate for 
high throughput processing.  Therefore, a liquid two-phase system was employed to 
precipitate bacteriophage-lysed bacterial cultures.  This system was a modified version 
as described in the literature (Vajda, 1978; Philipson, 1960; Leberman, 1966; 
Venekamp, 1964).  
! The host E. coli K12 was grown in 15 ml LB broth overnight at 37%.  After 
incubation, 10 ml of E. coliI culture was transferred to 190 ml of pre-warmed (37%) LB 
broth and incubated at 37% until the O.D.600 measured 0.45, indicating exponential 
growth phase.  At this point, 50 ml of phage stock at 5x109 pfu/ml was added and mixed 
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with the culture.  The infected culture was incubated for 2-3 hours at 37% until visible 
lysis occurred.  When lysis was observed, characterized by clearing and cellular debris 
accumulation in the medium, the culture was transferred to a sterile 500 ml separation 
flask at 4%.  In the cooled separation flask, 4.375 g of NaCl (Fisher Scientific, 
Hampton, NH) was thoroughly mixed into solution and incubated at 4% for 1 hour.  After 
incubation, 16.25 g of PEG-8000 m.w. (Promega, Fitchburg, WI) and 0.5 g of Dextran 
Sulfate (Fisher Scientific, Hampton, NH) were added to the 250 ml total volume culture 
and the flask was inverted several times until all added compounds were in solution.  
The culture was kept at 4% overnight to allow for bacteriophage precipitation.  After the 
precipitation incubation, the bottom layer of the solution containing the cellular debris 
and other contaminants, was removed via the separation apparatus on the flask and 
discarded.  The supernatant was transferred to a sterile polypropylene tube and 
centrifuged at 11,000 g for 10 minutes at 4%.  The supernatant was discarded, any 
residual fluid was removed by pipette aspiration, and the tubes were inverted for 5 
minutes at room temperature to allow any remaining liquid to drain away.  The 
bacteriophage-containing pellet that was formed on the wall of the polypropylene tube 
was resuspended in 5 ml of SM buffer by using a wide-bore pipette and the tube was 
placed on its side for 1 hour to allow the SM buffer to saturate and soak the pellet.  Any 
remaining cell debris and PEG was extracted from the bacteriophage suspension by 
adding 5 ml of chloroform and gently vortexing the mixture for 30 seconds.  The mixture 
was then centrifuged at 3000 g for 15 minutes at room temperature and the 
bacteriophage-containing aqueous phase was transferred to a sterile glass tube.  The 
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phage stocks were then serially diluted to produce a pfu/ml value for the solution, 
thereby indicating the quantity of viable phage in solution.  Additionally, the chloroform 
step performed after the PEG extraction process was replaced with a syringe filtration 
step through a 0.2 µm filter, which was found to be comparably effective at purifying 
phage stocks.  This was done by transferring the resuspended bacteriophage-
containing pellet to a sterile 5 ml syringe with a 0.2 µm filter disc peripheral attached to 
the syringe tip.  The solution was passed through the filter into a sterile glass tube and 
stored at 4% for plaque assay applications.
DNase I Treatment
! The endonuclease, DNase I, was utilized as a means for degrading 
contaminating DNA in samples.  The optimization of the enzyme"s capabilities was 
intended to provide a method to purify bacteriophage particles of host DNA in solution.  
The effective conditions for DNase I activity were investigated by creating a gradient of 
added metal ions (MgCl2) to the solution after bacterial cultures were lysed and 
preliminarily filtered.  Bacterial cultures of E. coli K12 pGlowBs2Stop were grown 
overnight in 25 ml of LBamp100 at 37%.  The culture was then lysed by the addition of 2.5 
ml of chloroform and incubated for 10 minutes at 37%.  The lysed culture was then 
centrifuged for 10 minutes at 10,000g at room temperature and the supernatant was 
subsequently transferred to a sterile syringe and filtered through a 0.2 µm filter into a 
sterile polypropylene tube.  Aliquots of varying volumes of the supernatant were 
transferred to 1.5 ml polypropylene tubes for DNase I treatments (Table 6).  The 
variable volumes of supernatant added allowed for final concentrations of MgCl2 to be 
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precise.  To each tube of bacterial culture supernatant, 20 units of RNase- free DNase I 
(New England Biolabs, Ipswich, MA) was added.  A gradient of MgCl2 concentrations of 
10 mM, 20 mM, and 30 mM were added to the reaction tubes (Table 6).  In addition to 
these experimental conditions, supernatant with metal ions, supernatant-only, raw 
culture-only, DNase I-only, and DNase I with metal ion controls were prepared in 
parallel.  The reactions were incubated according to the manufacturer"s protocol at 37% 
for 10 minutes and heat inactivated by incubating the reactions at 75% for 10 minutes.  
The reactions were then used as templates for PCR verification using pGlow and gfp 
primer sets (Table 2).  The PCR thermal cycling conditions and reaction tube volumes 
were identical to those previously described (Table 3).  The PCR products and wide 
range DNA ladder (Takara) were loaded into a 150 ml volume, 1% agarose gel with 7 µl 
ethidium bromide  and 60V were applied to the gel electrophoresis reaction for 45 
minutes.  The gel was viewed under an ultraviolet light and photodocumented.
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Table 6.  DNase I treatment conditions for PCR verification
Reaction 1 2 3 4 5 6 7 8 9
Supernatant
(volume)
14.5 µl 14 µl 13.5 µl 25 µl 24.5 µl 24 µl 23.5 µl 25 µl
(raw 
culture)
15 µl
DNase I
(volume)
10 µl
20 Units
10 µl
20 Units
10 µl
20 Units
0 µl 0 µl 0 µl 0 µl 0 µl 10 µl
20 
Units
MgCl2
(volume)
0.5 µl
(0.5 M 
stock)
1 µl
(0.5 M 
stock)
1.5 µl
(0.5 M 
stock)
0 µl 0.5 µl
(0.5 M 
stock)
1 µl
(0.5 M 
stock)
1.5 µl
(0.5 M 
stock)
0 µl 0 µl
MgCl2
(final 
concentration)
10 mM 20 mM 30 mM 0 mM 10 mM 20 mM 30 mM 0 mM 0 mM
2
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Realtime Quantitative Polymerase Chain Reaction
! Quantitative PCR (QPCR) was used to measure transduction events in controlled 
batch cultures.  The batch cultures represented a grossly simplified interaction scenario 
between bacteriophage T4 and a single host, E. coli K12, that possessed the 
pGlowBs2Stop plasmid harboring marker genes.  The previously described primer sets 
for ampR, pGlow, and gfp amplicons were used for QPCR analysis.  
! The host E. coli K12 pGlow Bs2Stop was grown in 500 ml of LBamp100 to an O.D.
600 of 0.3 at 37%.  When optimum optical density was achieved, biotinylated 
bacteriophage T4 was added at multiplicity of infection (MOI) of 1.0.  The infected 
culture was incubated at 37% for 4 hours.  After bacteriophage-induced lysis of the 
culture, the previously described CsCl density gradient coupled with PEG precipitation 
method was applied.  The bacteriophage-containing band was aseptically extracted 
from the ultracentrifuge tube and serially diluted to quantify infectious bacteriophage 
particles in the solution.  The plaque assay served as the enumerating agent in 
standardizing bacteriophage T4 genome copies in QPCR due to the stringent conditions 
found in the density gradient.  The density gradient theoretically collects only intact viral 
particles in the designated region above 1.50 g/ml of CsCl.  This purified bacteriophage 
sample was then used for genomic DNA extraction via the formamide protocol, as 
previously described.
! The phage genomic DNA was serially diluted and used as template DNA in 
QPCR for the marker genes.  Brilliant II QPCR Master Mix (Stratagene, La Jolla, CA) 
was used as the fluorescent agent according to the manufacturer"s protocol.  Each 
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QPCR set was prepared in white, 96-well plates in a laminar fume hood.  The reaction 
components are described in Table 7, with primers being interchanged for each marker 
gene primer set (Table 2).  The QPCR thermocycler was programmed according to 
Table 8, and all data were analyzed using Numbers software (Apple Inc, Cupertino, CA).
Table 7.  QPCR reagent distribution.
Reagent Volume per Well
Master Mix 12.5 µl
Bovine Serum Albunim (BSA) 1.0 µl
Forward Primer (5 µM) 1.0 µl
Reverse Primer (5 µM) 1.0 µl
Sample Template 2.5 µl
ddH20 7 µl
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Table 8.  QPCR thermal cycling protocol for pGlow, ampR, and gfp primer sets.
Step Temperature Time
1 50% 2 minutes
2 95% 15 minutes
3 95% 1 minutes
4 60% 30 seconds
5 Plate Read n/a
6 72% 30 seconds
7 Plate Read n/a
8 85% 30 seconds
9 Plate Read n/a
10 Repeat Steps 3-9, 45 times n/a
11 65%-95% melting curve read every 1%, holding 5 seconds b/w reads
Streptavidin Paramagnetic Particle Recovery of Biotinylated Bacteriophage T4
! The biotin-binding protein that was fused to the small outer capsid of 
bacteriophage T4 theoretically allowed for the virus" recovery via the strong non-
covalent bond between avidin, or its biological relative, streptavidin, and biotin 
molecules.  Thus, commercially available Dynabeads® MyOne™ Streptavidin C-1beads 
(Invitrogen, Carlsbad, CA) were used as a means to recover the biotinylated 
bacteriophage T4 particles from solution due to their higher binding capacity for biotin.  
Phage stocks that were produced using the aforementioned two-phase polymer 
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precipitation system at a concentration of 9x1010 pfu/ml were applied to the 
Dynabeads® MyOne™ Streptavidin C-1 beads according to the manufacturer"s 
recommended protocol with a minor modification with regard to the number of washes 
the beads were exposed to.  The beads were prepared by resuspension in the original 
vial through rotating and vortexing.  The washing buffer, 1 ml sterile PBS pH 7.4, was 
mixed with 100 µl of resuspended beads (1 mg of beads) in a sterile polypropylene tube 
and subsequently placed on a Dynal® MPC™ magnet for 2 minutes at room 
temperature.  A pipette was used to remove the supernatant while the tube remained on 
the magnet.  The tube was removed from the magnet and the beads were resuspended 
in 100 µl of sterile PBS (pH 7.4).  This washing process was repeated two additional 
times to further remove preservatives from the bead solution.  After the final wash, the 
supernatant was removed and replaced with 1 ml of phage stock containing 9x1010 pfu/
ml and incubated for 30 minutes at room temperature with gentle rotation.  The beads 
were collected on the magnet for 3 minutes at room temperature and the supernatant 
removed with a pipette.  The tube containing the collected beads was then removed 
from the magnet and the beads were resuspended in 100 µl PBS containing 1% BSA.  
This washing and resuspension method was repeated eight times and the washing 
buffer was transferred to a sterile polypropylene tube each time for plaque assay 
analysis.  Following the final wash, the beads were resuspended in 100 µl of ddH2O and 
incubated at 70% for 3 minutes to break the biotin-streptavidin bond, releasing the 
biotinylated bacteriophage particles.  The beads were immediately collected using a 
magnet and the supernatant was transferred to a sterile polypropylene tube for plaque 
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assay analysis.  An identical experiment was performed with the modification of adding 
four additional wash steps, for a total of eight washes, to observe any changes in 
binding and recovery characteristics of streptavidin-bound bacteriophage.  The same 
phage stock solution, buffers, and streptavidin bead type were used in this modified 
extension of the previously described experiment.  
! All supernatant wash solutions collected during the experiment were serially 
diluted and plated onto host E. coli K12-containing LB top agarose.  The ddH2O solution 
containing the released bacteriophage particles were subjected to the same serial 
dilution and plaque assay treatment.  The plates were incubated at 37% in the dark 
overnight and plaque titers were determined by counting pfu"s on the top agarose 
plates.  All samples were processed in triplicate and the data were analyzed using 
Prism 4 software (Graphpad Inc).
Western Blot Analysis of Biotinylated Bacteriophage T4
! Western blots were performed to verify the BCCP gene"s functionality and 
presence in the T4 bacteriophage.  The biotinylated bacteriophage T4 samples were 
measured to be at concentrations of 1x1010 pfu/ml and used as the experimental 
samples in the protein analysis.  A S. cerevisiae-derived biotinylated protein, T199 
PBEC2, was used as the positive control (30 µg/lane) due to its confirmed biotinylated 
status and highly-concentrated samples (Becker Lab, Knoxville, TN).  The wild-type 
lambda phage (2x109 pfu/ml) acted as the negative control.  Under two conditions, 65% 
for 10 minutes and 90% for 5 minutes, 1 ml of each phage solution was denatured and 
membranes were solubilized in 10% sodium dodecyl sulfate (SDS) sample buffer.  Two 
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volumes of each denaturation condition were loaded into the gel lanes:  30 µl and 60 µl 
(Figure 15).  Proteins were fractioned by SDS-polyacrylamide gel electrophoresis 
(PAGE) and immunoblotted.  Blots were probed with Pierce Neutravidin +HRP 
conjugate (Thermo Scientific, Waltham, MA) and imaged on a ChemiDoc-XRS 
photodocumentation system (BioRad, Hercules, CA).  The protein bands were 
measured using PageRuler™ prestained protein ladder (Fermentas, Glen Burnie, MD).  
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Figure 3.  Overview of experimental methods utilized in the study.
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Table 9.  Chemical solutions used in sample processing and growth media.  All 
chemicals were obtained from Fisher Scientific (Hampton, NH).
Chemical Solution Concentration Chemical Solution Concentration
Luria-Bertani Broth 10 g/L Tryptone Super Optimal Broth
with Catabolite 
Repression
20 g/L Bacto tryptone
5 g/L Yeast extract 5 g/L Yeast extract
10 g/L NaCl 0.5 g/L NaCl
ddH2O to 1 L 0.186 g/L KCl
$ salt Luria-Bertani 
Broth
10 g/L Tryptone 0.952 g/L MgCl2
5 g/L Yeast extract 3.063 g/L Glucose
5 g/L NaCl ddH2O to 1 L
ddH2O to 1 L
Tris-borate EDTA 
Buffer (5X)
54 g/L Tris base
27.5 g/L Boric acid
20 ml 0.5 M EDTA
ddH2O to 1 L
SM Buffer 5.8 g/L NaCl
2.0 g/L MgSO4*7H20
50 ml/L 1M Tris-HCl (pH7.5)
ddH2O to 1 L
TE Buffer 10 ml/L 1M Tris-HCl (pH 8.0)
2 ml/L 0.5M EDTA (pH 8.0)
ddH2O to 1 L
PBS Buffer (pH 7.4) 0.26 g/L NaH2PO4*H2O
1.44 g/L Na2HPO4* H2O
8.78 g/L NaCl
ddH2O to 1 L
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Results
Genetic Construction of E. coli K12 host
! The marker genes ampR, gfp, and pGlow were confirmed to be present on the 
plasmid pGlowBS2STOP through mini-prep purification and PCR confirmation (Figure 
3).  The plasmid pGlowBS2STOP, containing marker genes (GFP, pGlow, and AmpR), 
was electroporated into E. coli K12, producing over 300 colonies, and 24 colonies were 
isolated for PCR analysis.  Mini-prep purification produced pGlowBS2STOP DNA 
concentrations of 35ng/µl in 50µl volumes, resulting in a total of 1.75 µg of plasmid 
DNA purification.  The success of the electroporation was indicated by the PCR and gel 
electrophoresis results (Figure 3).  The reference ampicillin resistance amplicon (ampR) 
was 104bp in size, gfp marker gene (gfp) was 483bp, and the evoGlow (pGlow) marker 
gene was 219bp long.
Genetic Characterization of Bacteriophage T4
! The presence of the biotin carboxylase carrier protein (BCCP) and T4e lysozyme 
genes in the BCCP-fused bacteriophage T4 were confirmed by PCR and gel 
electrophoresis (Figure 4).  The template phage genomic DNA used for molecular 
confirmations was found to be at concentrations of 317ng/µl in 50µl volumes after 
formamide DNA extraction.  The PEG/NaCl precipitation protocol produced phage titers 
of 1011 pfu/mL and ultracentrifugation through CsCl gradients produced a visible band of 
viral particles, resulting in final plaque titers of 108 pfu/mL.  The formamide genomic 
DNA extraction resulted in 15.85µg of total genomic DNA. The subsequent TOPO-TA 
cloning reaction to produce plasmid standards for QPCR analysis resulted in successful 
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integration of the BCCP and T4e genes into a pcr2.1 cloning vector and TOP10 E. coli 
cells (Figure 5).  The PCR and gel electrophoresis results showed no amplification in 
the negative, no-template controls for both primer sets.  The positive control, containing 
295ng BCCP-fused T4 genomic DNA showed visible gel bands for both T4e and BCCP 
genes, indicating successful amplification of the target genes (Figure 5).
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Figure 4.  Marker gene confirmation of pGlow BS2 Stop.  Template DNA consisted 
of mini-prep purified pGlow BS2 Stop plasmid, aliquoted at 300 ng per reaction.  
Negative controls consisted of template-free reactions.  
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Figure 5.  Gel electrophoresis of PCR product for BCCP (Bio) and T4e genes from 
biotinylated bacteriophage T4 genomic DNA.  Both positive reaction lanes were 
loaded with 317 ng template DNA, while the negative reactions indicate template 
free, negative controls.
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Figure 6.  Gel electrophoresis of PCR products resulting from TOPO-TA cloning 
BCCP (Bio) and T4e genes into pcr4 plasmid hosted in E. coli TOP10 cells.  Three 
colonies are presented for each cloning reaction, each of which indicates 
successful cloning when compared to positive controls using biotinylated 
bacteriophage T4 genomic DNA.  Both no-template controls for each primer set 
support the PCR results from the cloning reactions.
39
Multiplicity of Infection Optimization
! The growth characteristics of the host E. coli K12 were observed by comparing 
the optical density of growth cultures, time, and colony forming unit quantification 
(Figures 6-7).  These results show that after seven hours of growth at 37% with shaking 
at 200 rpm, 1mL of overnight culture added to 100 mL of fresh LB medium produced an 
O.D.600=0.4, which is indicative of the host E. coli being in exponential growth phase 
(Sezonov, 2007).  The most effective period of bacterial batch culture growth for phage 
production has been shown to be during logarithmic growth phase (Hadas, 1997).  
The optimal multiplicity of infection (M.O.I.) was found to be 0.5 based on observed 
phage propagation.  Effective M.O.I. ranges may vary based on environmental and 
growth conditions, however, the initial M.O.I. value of 0.5 provided productive results for 
this study.  Overnight culture was grown to an O.D.600=0.98 prior to phage inoculation.  
After dilution and phage inoculation at a M.O.I. of 0.5, the O.D.600=0.45.  After three 
hours of co-incubation, the O.D.600 had dropped to 0.125 with visible lysis defined by an 
increased accumulation of cellular debris in the medium solution.  The subsequent 
plaque assay to determine bacteriophage propagation produced titers of 2x109 pfu/ml in 
200 ml solution.
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Figure 7.  Optical density measurements compared with time of incubation for 
host E. coli K12 pGlow BS2 Stop.  Source cultures were grown in triplicate and 
measured simultaneously using the same spectrophotometer.  Statistical analysis 
was performed with Prism 4 (GraphPad Software Inc, La Jolla, CA).
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Figure 8.  Graphical representation of optical density (600 nm) measurements of 
E. coli K12 pGlowBS2Stop growth characteristics compared to viable cell counts 
in quantities of colony forming units (CFU) per mL.  A correlation between optical 
density measurements and CFU/mL was observed and factored into the 
optimization for multiplicity of infection experiments.  Statistical analyses were 
performed using Prism 4 software (GraphPad Software Inc., La Jolla CA).
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Bacteriophage Purification and Concentration
! The most efficient results for T4 bacteriophage purification and concentration 
were obtained through the polyethylene glycol-dextran sulfate, two-phase system.  In 
addition to the two-phase PEG-Dextran Sulfate polymer system of bacteriophage 
precipitation, filtration through 0.2µm filter produced exceptional phage yields.  The 
primary advantage of the two-phase polymer system was the concentration effect.  
Cultures of E. coli K12 that were infected with bacteriophage T4 at M.O.I.=1 that were 
treated with chloroform, centrifuged at 10,000xg and filtered through 0.2µm filters 
produced phage stocks containing 2x108 pfu/mL.  The PEG-Dextran sulfate two-phase 
system produced phage stocks that contained 1x1011 pfu/mL.  The concentration effect 
was observed in the two-phase system of phage precipitation due to the total volume 
being reduced by half during processing and removal of the phage-containing phase.  
The replacement of the chloroform precipitation of PEG and cellular debris with filtration 
through a 0.2 µm filter after re-suspending the phage-containing pellet produced no 
observable phage loss after performing plaque assays on the resulting solutions and no 
bacterial contamination was shown to occur in either product.  The chloroform and 
filtration-only treatment resulted in the same volume of phage stock, albeit at lower pfu/
ml values, as the original culture due to minimal removal of any liquid during processing.
In addition to the previous two approaches to bacteriophage purification, the CsCl 
density gradient with ultracentrifugation method resulted in erratic phage titers and 
observable bacterial colony growth on plaque assay plates, indicating possible bacterial 
contaminant residue.  Ultracentrifugation through CsCl density gradients was 
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determined to be low-throughput and inefficient for producing consistently pure phage 
solutions.
DNase I Treatment 
! Deoxyribonuclease I was found to be most enzymatically active in the presence 
of metal ions, specifically MgCl2.  PCR and gel electrophoresis performed after DNase I 
treatment of E. coli K12 pGlowBS2STOP lysed cells initially showed that DNase I 
degraded DNA efficiently at 5mM MgCl2 concentration (Figure 8).  Concentrations of 
MgCl2 that exceeded 10mM showed lower enzymatic activity and metal-only controls 
that were not exposed to DNase I indicated that the metal ion did not affect the PCR to 
produce false negative results (Figures 8-9).  Additionally, the reaction that was exposed 
to DNase I, but did not contain additional MgCl2 produced the same gene amplification 
as the metal-only controls and the reactions with higher MgCl2 concentrations (Figures 
8-9).  Both figures (Figure 8-9) represent lysed E. coli cultures containing the pGlowBS2 
STOP plasmid after DNase I treatment with varying MgCl2 concentrations after PCR 
amplification of the gfp marker gene amplicon.
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Figure 9.  Gel electrophoresis of the gfp amplicon PCR product after lysed E. coli 
culture after exposure to DNase I.  These findings indicated that 5 mM MgCl2 was 
optimal for DNase I activity, leaving observable amounts of template DNA to be 
amplified in the subsequent PCR.  All reactions utilized the gfp primer set for PCR 
and compared metal ion gradients with crude E. coli K12 pGlowBS2Stop culture, 
no DNase I, purified pGlowBS2Stop plasmid, and no template controls to alleviate 
numerous affecting factors.
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Figure 10.  Gel electrophoresis of the gfp amplicon PCR product after lysed host 
cell supernatant exposure to DNase I and varying concentrations of MgCl2.  The 
optimal concentration of MgCl2 was shown to be at 10 mM, while higher 
concentrations were indistinguishable from the positive controls.  Metal-only 
controls included in the PCR batch produced no observable interference in the 
polymerase reaction and positive controls indicated proper primer function.
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Realtime Quantitative Polymerase Chain Reaction
! The results for quantifying horizontal gene transfer in batch culture controls 
indicated transduction frequency was measurable.  The ampR indicator gene was found 
to be in equal quantities to the calculated number of phage genome copies in the 
reactions.  The standard deviation for the phage genome quantities of 105 was 2.6x104, 
however, the measurements for phage genomes at quantities of 104 were shown to 
have a much smaller standard deviation value at 5.8x103.  The QPCR results for the 
pGlow primer set indicated that the number of gene copies was slightly lower than the 
number of calculated phage genome copies.  At phage genome numbers at 105, the 
number of pGlow copies was shown to be 2.3x104, with a standard deviation value of 
1.4x103.  At phage genome copies of 104, the number of pGlow gene copies was 
1.5x103, with a standard deviation of 1.2x102.  The third indicator gene used was gfp, 
which showed that the gene was measured at slightly lower levels than the phage 
genome.  At phage genome copy numbers of 105, gfp was shown to be quantified at 
levels of 1.1x104, with a standard deviation of 1.4x103.  At phage genome numbers of 
104, gfp was measured to be 9.3x102, with a standard deviation of 2.9x102.  The 
standard curves for the QPCR analyses indicated accurate quantification, with r2 values 
all surpassing 0.994 (Figures 10-12).
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ampR
Template C(T) Copies Average Standard Deviation
T4 105 16 1.28 x 105 1.46 x 105 2.67 x 104
T4 105 16 1.30 x 105
T4 105 16 1.85 x 105
T4 105 16 1.40 x 105
T4 104 19 1.15 x 104 1.64 x 104 5.88 x 103
T4 104 19 1.15 x 104
T4 104 18 2.32 x 104
T4 104 19 1.95 x 104
Figure 11.  QPCR data for ampicillin resistance gene (ampR) standards.
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pGlow
Template C(T) Copies Average Standard Deviation
T4 105 19 2.44 x 104 2.29 x 104 1.44 x 103
T4 105 19 2.36 x 104
T4 105 19 2.24 x 104
T4 105 19 2.11 x 104
T4 104 23 1.47 x 103 1.51 x 103 1.20 x 102
T4 104 23 1.60 x 103
T4 104 23 1.60 x 103
T4 104 24 1.35 x 103
Figure 12.  QPCR data for evoglow gene (pGlow) standards.
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gfp
Template C(T) Copies Average Standard Deviation
T4 105 18 9.78 x 103 1.08 x 104 1.41 x 103
T4 105 18 9.56 x 103
T4 105 18 1.12 x 104
T4 105 18 1.26 x 104
T4 104 21 1.23 x 103 9.25 x 102 2.88 x 102
T4 104 22 6.67 x 102
T4 104 22 6.91 x 102
T4 104 21 1.11 x 103
Figure 13.  QPCR data for fluorescent protein gene (gfp) standards.
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Streptavidin Paramagnetic Particle Recovery of Biotinylated Bacteriophage T4
! The recovery efficiency for biotinylated phage from streptavidin paramagnetic 
particles was found to be highly inefficient.  From a starting stock of biotinylated 
bacteriophage T4 at concentrations of 9x1010 pfu/mL, 1mg of Dynabeads© MyOne™ 
Streptavidin recovered 7x107 pfu/mL with a standard deviation of 1x108.  Each of the 
four washes with PBS buffer was used in a plaque assay for quantifying phage contents 
in solution.  The PBS wash buffer from the first wash procedure produced 6x109 pfu/mL 
with standard deviation of 1x109.  The second wash with PBS contained 8x108 pfu/mL 
and a standard deviation of 2x108.  PBS buffer from the third bead rinse produced 3x108 
pfu/mL with standard deviation of 1x108.  The final wash contained 7x107 pfu/mL and a 
standard deviation of 1x108.  After exposure to 70% H2O for five minutes, the 
streptavidin beads produced phage titers that were reduced by two orders of magnitude, 
indicating significant loss of phage particles during binding and washing the 
streptavidin-bound bacteriophage particles (Figure 13).  An additional eight-wash 
experiment produced corresponding results in that each wash contained diminished 
quantities of bacteriophage particles for each plaque assay performed on the 
streptavidin bead supernatant.  A minor increase was observed in the later washes 
(wash 8 and pre-heat wash), however, staying within one order of magnitude.  The heat-
released bacteriophage titer produced a final concentration of 2x108 pfu/mL, an 
increase of one order of magnitude from the pre-heat solution, but a total loss of two 
orders of magnitude, or approximately 1% recovery, from the original phage stock 
(Figure 14).  
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Figure 14.  Biotinylated bacteriophage titers of four washes after exposure to streptavidin 
particles and subsequent phage titer of heat-released bacteriophage solution.
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Figure 15.  Biotinylated bacteriophage titers of eight washes after exposure to streptavidin 
particles and final viable bacteriophage recovery efficiency after heat-induced release.
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Western Blot Analysis of Biotinylated Bacteriophage T4
! The status of biotinylation for the bacteriophage T4 sample indicated no reaction 
to Neutravidin (+ horse radish peroxidase) as a result of Western blot analysis.  The 
band representative of biotinylated BCCP bound to Neutravidin was not visible in the 
desired ~82-92 kDa region of the protein ladder, whereas the 30 µg of biotinylated T199 
PBEC2 protein showed a very strong reaction.  The volumes of bacteriophage samples 
loaded into the gel represent approximately 107 pfu per lane.  All temperature and 
exposure time denaturation steps for the biotinylated T4 and wildtype ( phage produced 
negative results.  The T4 bacteriophage did not produce qualitative evidence that 
supports the hypothesis that it is biotinylated with regard to established avidin reactions 
(Figure 15).
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Figure 16.  Western blot of biotinylated bacteriophage T4 coupled with avidin 
homolog after heat-induced lysis of phage solutions.  Parallel controls with w.t. $ 
phage (negative control) and T199 pBEC2 (positive control).
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Discussion
! The ability for biotinylated bacteriophage to act as biotechnological models for 
exploring their role in microbial community transduction events has been the focus of 
this work.   The technical approaches used to exploit modified phage biophysical 
characteristics as a window into gene transfer risk assessment have been thoroughly 
examined and refined.  This study has employed numerous molecular techniques in 
manipulating host genetics as well as genetic diagnostics to elucidate and confirm 
analytical progress toward the major goal of exploring the role of phage as gene transfer 
agents in natural systems.  A comprehensive examination of bacteriophage propagation 
and purification methods has been undertaken during this work, which resulted in 
various modifications central to the advancement of this technology.  The information 
produced from these experimental conglomerations provides a framework for a deeper 
understanding of bacteriophage as instruments of evolutionary and genetic analyses.
! The host bacterium, E. coli K12-12017, was used as a model host system for the 
biotinylated bacteriophage T4.  This host E. coli system allowed for the successful 
electroporation of a plasmid, pGlowBS2Stop, which contained three discrete marker 
genes that were dually used as confirmation of successful molecular protocols and as 
initial indicators for calibrating quantitative genetic analyses on phage genomic DNA.  
Additionally, targeting genes located on plasmid DNA within the host bacterium held 
potential for deciphering the transduction rates of genes distinct from the transduction 
events derived from host genomic DNA.  The pGlowBS2 STOP plasmid is produced in 
high copy numbers within the host bacteria, thus providing a parallel for high copy 
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number plasmids found in natural ecosystems.  This feature of the plasmid being in 
higher copy numbers than the genome theoretically allows for an increased probability 
of plasmid-derived transduction event occurrences.  While the increased copies of 
plasmid-based DNA may allow for an increased likelihood of transduction, studies have 
shown that the transduction rate discrepancies between genomic DNA and plasmid 
DNA in marine environments is negligible (Jiang, 1998).  Standard electroporation, 
plasmid DNA purification, and polymerase chain reaction (PCR) techniques were 
effective for characterizing the modified host bacterial strain as well as genetic 
verification of the biotinylated bacteriophage T4 sample.  All PCR primer sets produced 
substantial evidence for the observable presence of the genes of interest through gel 
electrophoresis of PCR products, whether in the bacteriophage or host bacterium 
(Figures 3-5).  As numerous studies have concluded, amplification of PCR products 
does not provide definitive evidence for the presence of functional genes, however, the 
E. coli possessing pGlowBS2Stop did exhibit sufficient ampicillin resistance to allow for 
bacterial culture growth to occur in selective media.  The PCR evidence coupled with 
the functionality of the ampicillin resistance gene present on the electroporated plasmid 
supports the accuracy of PCR products as indicators of gene fidelity in the host 
bacteria.  While no selective chemical agents were applied directly to bacteriophage 
cultures, the wild-type T4 e lysozyme amplicon was successfully PCR amplified.  The 
successful amplification of a fragment of the T4 lysozyme gene coupled with successful 
bacterial host lysis provides evidence that the bacteriophage strain under examination 
effectively utilizes lysozyme to lyse host cells.  While the amplification of the T4 
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lysozyme gene supported the hypothetical presence of the enzyme in its functional 
form, it has been shown that T4 holin gene can act as a substitute for bacterial lysis 
during T4 infection under special circumstances (Kao, 1980).  The fidelity of the BCCP 
gene is contingent upon the aforementioned logic applied to PCR"s ability to act as a 
successful indicator of the presence of a functional gene.  The interpretation of these 
initial molecular results indicate the limitations of using PCR as a tool for genetic 
analysis and provides conceptual arguments for how the reliability of the results of the 
reaction can be improved upon.  However, the PCR results produced in this study 
provided positive genetic evidence for the presence of these genes in the bacteriophage 
under investigation.
! The multiplicity of infection (MOI) is the ratio of infectious phage particles to host 
cell targets and can vary considerably between phage and host species.  Understanding 
host growth dynamics under defined conditions is critical to observing optimal MOI"s for 
a corresponding phage.  The elucidation of a relationship between the growth state of 
the host culture and its measurable optical density during incremental times of 
incubation provides a means to define the optimal conditions for desired phage 
infection.  As each batch experiment varies due to deviations in growth medium 
components and incubation conditions, related scientific literature only provides a 
framework for designing such an experiment.  A thorough investigation included defining 
the growth state of the host cell culture by comparing viable cell count assays with 
defined E. coli K12 growth properties (Sesenov, 2007).  The optical density 
measurements were used to define a relationship between incubation conditions and 
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the growth state of the host cell culture.  This experimental approach produced positive 
results for determining the ideal growth state of the host cell culture for phage 
propagation.  The desired MOI was determined through monitoring host cell culture 
optical density for decreasing turbidity, thus indicating cellular lysis.  The successful 
propagation of phage was semi-quantitatively analyzed through plaque assays to 
determine fluctuations in infectious particle numbers.  This system for determining the 
ideal growth phase of the host cell culture through optical density measurements and 
the subsequent phage inoculation produced favorable phage-induced lysates.  The 
applied MOI of 0.5 likely resulted in superinfection of some host cells, which has been 
shown to not only delay lysis, but increase the number of progeny phage released 
indicated by larger burst sizes (Bode, 1967).  Not only did this approach indicate an 
effective method for propagating the viral particles specific to this study, but provided 
positive evidence for the efficiency with which the recombinant bacteriophage T4 can 
infect the experimental host E. coli K12 model under specifically defined incubation 
conditions.  
! Deciphering the most efficient and effective means with which to concentrate and 
purify the BCCP-fused bacteriophage T4 was a central component to this study (Figure 
3).  Historical published methods for virus purification were extensively explored with 
emphases on cesium chloride density gradients, polyethylene glycol precipitations, 
ultracentrifugation, physical filtration, and endonuclease activity.  This work has 
examined these experimental techniques as isolated means for viral purification as well 
as their combinatory effects.  
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! The principal concept of the cesium chloride (CsCl) density gradient is to isolate 
viable, highly concentrated, host nucleic acid-free phage samples by targeting phage 
buoyant densities through isopycnic centrifugation (Yamamoto, 1970).  This technical 
approach is commonly reliant on the tendency of phage to congregate at the interface of 
two-phase systems employing the polyether compound, polyethylene glycol (PEG), and 
either high salt (NaCl) concentrations or dextran sulfate additions (Bachrach, 1971; 
Vajda, 1978).  In addition to CsCl density gradients and PEG precipitations, the 
endonuclease, DNase I, was integrated into this study to alleviate residual host DNA 
contaminants.  Due to the inefficiencies produced by these methods in combination with 
one another, this study systematically isolated each technique to determine avenues for 
streamlining and increasing efficiency.  Cesium chloride gradients provided an inefficient 
and unreliable approach for purifying the subject bacteriophage in the laboratory.  The 
observed fluctuations and bacterial contamination provided evidence for the delicate 
nature of this protocol.  The mechanics of overlaying CsCl concentration gradients 
provided numerous opportunities for mixing, thus robbing the gradient of its density-
based concentrating capabilities.  Additionally, the transfer of collected phage bands 
among ultracentrifuge tubes, as required by the speed limitations of the tubes used for 
isopycnic ultracentrifugation, and the means of collecting the final phage band from the 
ultracentrifuge tube through penetration with a syringe needle had the potential to 
expose the samples to gradient perturbations and possible biological contaminants.  
Thus, the established methods utilizing CsCl density gradients and isopycnic 
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centrifugations were deemed to be rife with unsanitary conditions and subsequently 
abandoned as a means to purify bacteriophage particles for this work.
! The two-phase precipitation system provided satisfactory results in the quest for 
an effectively aseptic mechanism for concentrating phage.  This system allowed for 
every constituent to be sterilized with virtually no exposure to biological contaminants 
other than the phage and lysed bacterial host culture.  When applied under the 
previously described conditions, PEG and dextran sulfate exhibited the most 
advantageous route to bacteriophage concentration.  While the theoretical lack of 
purification properties for this technique are well founded, its concentrating 
effectiveness was easily supplemented with other purification processes.  The 
optimization and development of the use of an endonuclease provided an effective 
measure of compensating for the lacking purification properties of PEG concentration.  
An assay was designed to test the efficiency of DNase I as a means to degrade 
bacterial DNA in phage solution.  An essential tenet of this application, and subsequent 
optimization effort, was founded on the observation that DNase I was considered a 
metal-activated enzyme, specifically enhanced at specific metal ion concentrations 
(Eichhorn, 1969).  The results of this study showed evidence that magnesium chloride 
(MgCl2) ions at concentrations of 10 mM activated enzyme activity to a degree of 
effectiveness that resulting solutions produced no observable PCR amplification of 
target genes contained in the pre-endonuclease treated samples.  Due to the specificity 
of DNase I activity on polynucleotides, phage capsid proteins provide ample protection 
from enzymatic degradation of phage genetic material.  The requirement of metal ions 
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at specific concentrations is of particular significance to the use of endonucleases in 
phage purification processes.  Coupled with PEG precipitation and physical filtration, the 
findings of this technical application provided a useful method for concentrating and 
purifying bacteriophage samples. 
! The QPCR analysis performed in this study provided an ample framework for the 
use of this technology as a tool for enumerating phage-mediated transduction events in 
a natural ecosystem.  The significance of these QPCR findings should be understood as 
preliminary standards with an indication of positive evidence supporting hypotheses 
pertaining to transduction activity in bacteriophage T4 communities.  An evaluation of 
these QPCR standards unveiled an exploratory relationship between the amplified 
marker genes derived from the host E. coli K12 plasmid (e.g. ampR) and the calculated 
phage genome numbers, which suggested evidence for phage uptake of host gene 
sequences in batch culture bench experiments.  While it should be understood that 
these data primarily provide a source of comparison for samples of unknown gene copy 
numbers, it can be concluded that the prepared components of the QPCR protocol 
performed adequately and that future applications would provide more definitive 
evidence regarding the efficacy of this technique for purposes related to transduction 
event quantification.  Indirect measurements of phage genome numbers were 
calculated in this study based on phage genome size, molecular weight, and DNA 
concentrations.  These variables can differ within phage populations due to genomic 
variations produced from transduction events and contaminating DNA, thus skewing the 
projected number of phage genomes based on these values.  Additionally, amplifying 
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only a portion of a maker gene through QPCR does not provide definitive evidence of 
successful transduction of a functional gene, indicating the significance of amplifying 
entire genes through this approach.  The application of DNase I as a means to rid the 
phage particles of contaminating host DNA required extensive optimization for this study 
and the possibility of incomplete degradation of contaminating DNA should be noted.  
Furthermore, the plasmid containing the marker genes used for this study was produced 
in the host bacterium in high copy numbers.  This plasmid characteristic likely led to 
phage transducing DNA fragments derived from the high copy number plasmid more 
often than the host genome, due to the increased number of copies of the marker 
genes.  QPCR analysis targeting genes located on the host bacterial genome would 
provide data specific to transduction rates associated with genomic DNA.  The QPCR 
data produced from this study provides evidence for transduction rates related to 
plasmid DNA, which also play a critical role in natural ecosystems.  While the 
application of QPCR technology suggests further utility in the interest of measuring 
phage-mediated transduction events in the context of this study, the technical limitations 
should be carefully examined in order to avoid dissociated or convoluted evidence 
(Smith, 2008).
! The interactions between biotin and streptavidin were a central component of this 
investigation.  Streptavidin-coated paramagnetic particles were used in an attempt to 
recover biotinylated bacteriophage particles from solution, while excluding viruses or 
other biological entities that did not possess conjugated biotin.  The hypothetical 
concentrating effects of this assay did not produce the desired results of recovering high 
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titers of biotinylated phage.  A significant loss of phage numbers was observed after 
following the manufacturer"s treatment protocol.  The plaque assays performed on 
supernatants from each wash step provided convincing evidence for when the phage 
losses occurred.  These observations could be a result of high levels of free biotin in 
solution decreasing the efficiency of the streptavidin beads by occupying available 
binding sites, thereby competing with biotinylated phage for access to the sites.  The 
established protocol of breaking the biotin-streptavidin bond through elevated 
temperatures (70%) in water was shown to produce only slight increases in phage titers 
after an increased number of wash steps, indicating little effect on the final released 
phage quantities.  While this concept has been shown to produce repeatable results for 
a multitude of biotinylated molecules, evidence for the sustained viability of 
bacteriophage after this treatment has not been explored (Holmberg, 2005).  The 
decreased numbers produced by the plaque assays performed after the heat treatment 
may be the result of heat-inactivation of the phage or negative osmotic effects produced 
from the phage transfer to deionized water, however, the significant quantities of phage 
released during the washing steps supports the hypothesis that the phage were not 
efficiently bound to the streptavidin beads.  The combinatory effects of phage particles 
being exposed to washing solutions (PBS buffer), elevated temperatures, and the 
inherent osmotic changes inherent in water resuspension could contribute to a decrease 
in phage viability as measured by plaque assays.  Thus, the potential cleavage of the 
biotin-streptavidin bond through elevated temperatures in water should be further 
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examined in the context of how these parameters can effect the viability of 
bacteriophage.
! The exploration of measuring streptavidin recovery efficiency of the biotinylated 
phage was complimented by another avenue of inquiry, based on confirming the fidelity 
of BCCP functionality in the recombinant phage through Western blot analysis.  As the 
proposed streptavidin paramagnetic bead assay suggested undesirable phage 
recovery, Western blot analysis provided an alternative window into clarifying the 
functional state of BCCP through detecting its reaction with an avidin homolog 
(Neutravidin) acting as the primary antibody equivalent.  The results of this analytical 
survey strongly suggested the deactivation of BCCP as a functional protein in the 
bacteriophage stock samples.  While the phage titers used in this assay were measured 
to be approximately 1 x 1010 pfu/ml, the quantification assay was biased for viable 
phage particles, thereby not taking any immature or dysfunctional phage into account.  
Therefore, the titer values described in this assay should be considered an 
underestimation of actual phage particles present in solution.  Additionally, the targeted 
protein, BCCP, was previously confirmed to be fused to the small outer capsid (SOC) 
protein (Tolba, 2009).  This detail, regarding the protein to which BCCP was fused 
(SOC), provides further evidence that the actual quantities of viable phage is a gross 
underrepresentation of BCCP presence because between 810 and 960 copies of SOC 
are present in T4 phage capsids (Leiman, 2003; Baschong, 1991).  Therefore, it could 
be estimated that up to 960 BCCP molecules were present for each bacteriophage 
particle, thus providing further evidence to support the interpretation of these results as 
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indicating the loss of functionality of BCCP on the bacteriophage capsid.  Due to the 
genetic evidence supporting the presence of the BCCP gene in phage samples, a 
structural deviation within the target protein is a probable cause of these negative 
Western blot results.  The development and application of a BCCP-specific antibody 
could illustrate the presence of BCCP as an immunoblotting technique to circumvent the 
biotin-streptavidin binding utilized in this study.  This approach would not be reliant on 
the functionality of BCCP and host enzymes for biotinylation, but would be indicative of 
an immunoblotting reaction to the protein itself, thereby providing details as to where the 
biotinylation process malfunctioned.  Additionally, replicating the previously described 
immunoblotting procedure used in this study with the host E. coli K12 strain would 
provide evidence as to whether the host BCCP and related biotinylating enzymes were 
functional within the host bacterium without phage infection.  Due to the phage reliance 
on host biotinylating capabilities, the functional status of the host biotinylation machinery 
could provide additional evidence as to how infecting phage biotinylation failed.
! The intrinsic malleability of any biological entity, even within a closed system, 
plays a crucial role in understanding the results of this investigation.  It is difficult to 
determine the factor responsible for a mutation event or alteration of protein structure 
within any living organism, however, extrapolations can be made as to what may have 
contributed to the loss of phage biotinylation.  While a single, original phage stock was 
maintained throughout this study, the optimization of phage propagation and purification 
techniques may have subjected the phage samples to unintended evolutionary 
pressures.  For example, during batch growth experiments for phage propagation, 
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biotinylated phage may have been at a slight evolutionary disadvantage due to minor 
increases in protein synthesis requirements related to BCCP production.  This minor 
extra protein synthesis burden on the BCCP-possessing phage may have been 
significant enough to produce a selective advantage in any progeny phage that had a 
more efficient version, albeit dysfunctional, of the biotin-binding protein.  Additionally, 
SOC, which was the capsid protein that was fused with BCCP, is not required for 
bacteriophage T4 survival and propagation (Comeau, 2008).  The evolutionary 
advantages that SOC provides the phage include improved capsid stability from osmotic 
shock, alkaline pH, and temperature denaturation.  However, the growth media that 
were used for phage propagation in this study did not possess any of these 
environmental challenges.  The absence of these factors could produce a selective 
advantage for phage that had relinquished their replication burden of SOC production 
due to its nonessential nature, thus making BCCP expression on the phage capsid 
unsuccessful.  This scenario could be further compounded by any other selective 
advantage that the absence of SOC on phage capsids may have presented due to the 
rapid and efficiency-oriented goal of optimizing the multiplicity of infection assay.  The 
primary factor that was selected for in the phage propagation assays was the ability for 
phage to lyse bacterial host cultures effectively, thereby selecting for phage that were 
highly efficient with regard to replication and lysis.
! This work presents a distinct repertoire of analytical techniques that can benefit 
further investigations into the role of bacteriophage in horizontal gene transfer events.  
While numerous investigations have used biotinylation technology as a means to label a 
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variety of biomolecules, the limitations of biotinylating living microbes is less common 
and understood to a lesser degree.  The findings presented by this exploration into 
phage utility as a practical subject of biotinylation aids in understanding the deficiencies 
of this approach to genetic engineering.  Further success of this investigation may 
include isolating evolutionary successful bacteriophage from an environment in which 
the study is to be performed, thereby providing some alleviation to the selective 
pressures applied to a recombinant phage.  While selecting a reproductively successful 
phage from the environment that is under analysis may contribute to increased success 
with this biotinylation application, alternative sites of BCCP fusion should also be 
considered due to the dispensability of SOC in bacteriophage T4.  The intrusiveness 
and evolutionary effects of fusing BCCP to the SOC of bacteriophage has not been fully 
investigated, therefore, additional bacteriophage tagging mechanisms can be explored 
to enable a further understanding of phage-mediated transduction events in natural 
systems.  The results of this investigation have provided additional evidence supporting 
the investigator"s intellectual tendency to refrain from attempting to alter biological 
entities without considering the evolutionary repercussions of producing a selectively 
disadvantaged organism that is expected to maintain genetic integrity.  Genetic analysis 
of any DNA-based organism must avoid the myopic approach of trivializing the 
importance of environmental factors on human-based engineering efforts on all life 
forms, even in theoretically controlled experiments.  Understanding and developing 
genetic tools for furthering biological discoveries can only be properly exercised if the 
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subject environment is thoroughly understood, which has been properly exemplified in 
this work.
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